42.5 F
New York
Saturday, January 16, 2021

Cerecor Inc (NASDAQ:CERC) Trying To Hold Suddon Gains

Must read

Why Is Everyone Talking About Alpine 4 Technologies Ltd (OTCMKTS:ALPP) Stock?

Investors who are looking for fast-moving stocks have had have made options in recent days. One stock that certainly stands out is...

Nano One Materials Corp (OTCMKTS:NNOMF) Signs Cathode Evaluation Agreement: Stock Reacts

Over the past week, there have been many stocks that have managed to generate significant gains and one of those is Nano...

Grayscale Bitcoin Trust (OTCMKTS:GBTC) Extends Rally As Bitcoin Jumps

One of the bigger stories of the year so far has been the massive gains made by Bitcoin. This week BTC hit...

Plyzer Technologies Inc (OTCMKTS:PLYZ) Gains Momentum on High Volume: Now What?

One of the more notable gainers this week on the OTC is Plyzer Technologies Inc (OTCMKTS:PLYZ). The stock was in focus among...

Cerecor Inc (NASDAQ:CERC) has seen more than a 120% increase since the beginning of the month. The lift in price and action comes on no real substantial news. This clinical stage biopharma company is working on a treatment for depression that has had some setbacks. CERC released some strong findings from a new small study back in early May, but nothing this month, so this could mean that something is on the horizon.

The company’s main drug is an oral KOR antagoonist, which are proven to play a role in mood and addiction. CERC-501 has been observed to have activity in animal models of depression, substance withdrawal and dependence, and it has been generally well-tolerated in five human clinical trials.

Cerecor Inc (NASDAQ:CERC) reported their financials last month and the stock lifted on the news. There is a short breakdown here below.

Find out when $CERC stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

CERC reported a net loss of $2.0 million, or $0.19 per share, for the first quarter of 2017, compared to a net loss of $5.1 million, or $0.59 per share, for the first quarter of 2016.

Grant revenue was $0.4 million for the first quarter of 2017 and consisted primarily of revenue earned from our research and development grant awarded by the National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health (the “NIAAA Grant”). This grant provides us with additional resources to continue the development of CERC-501 for the treatment of alcohol use disorder. The Company did not have grant revenue for the first quarter of 2016 as grants were awarded later in 2016.

Research and development expenses decreased to $1.0 million for the first quarter of 2017, compared to $2.3 million for the first quarter of 2016. This decrease was driven primarily by the completion development of our Phase 2 clinical trials for CERC-301 and CERC-501 in late 2016.

General and administrative expenditures decreased to $1.3 million for the first quarter of 2017, compared to $2.6 million for the first quarter of 2016. This decrease was driven primarily by a reduction in executive salaries during the first quarter of 2017 and stock compensation expense of $0.6 million related to modification of stock grants in the first quarter of 2016.

As of March 31, 2017, cash and cash equivalents were $3.0 million and current liabilities were $2.7 million. On April 27, 2017, we sold additional shares of our common and preferred stock under a stock purchase agreement with Armistice Capital for gross proceeds of $5.0 million.

Cerecor Inc (NASDAQ:CERC) has a $45.07 million market cap with a little over 14 million shares outstanding. CERC took a serious tumble before the end of the year after its drug did not reach its expected endpoint – it was trading over $5 beforehand. Biotech stocks can rise and fall easily and the market can often overreact to drug trials (not saying that is what happened here), but we will have to wait and see what is brewing here for CERC. For continuing coverage on shares of $CERC stock, as well as our other breakout stock picks, sign up for our free newsletter today and get our next hot stock pick!

Latest article

Ozop Energy Solutions Inc (OTCMKTS:OZSC) Remains Volatile: Stock in Focus

Those who are looking to discover stocks that may have made big moves over the course of the past week could consider...

Data Storage Corp (OTCMKTS:DTST) Gets Sudden Attention: What’s The Buzz?

One of the stocks to have made significant gains this week was that of Data Storage Corp (OTCMKTS:DTST). The Data Storage Corporation...

A Closer Looks at American Battery Metals Corp (OTCMKTS:ABML) Developments

American Battery Metals Corp (OTCMKTS:ABML) is one of the stocks to have been in focus among investors over the course of the...

Why is Grayscale Ethereum Trust (ETH) (OTCMKTS:ETHE) In a Bearish Trend?

The Bitcoin rally over the past weeks has taken the crypto space by storm. However, it should not be forgotten that Ethereum,...

Curaleaf Holdings (OTCQX:CURLF) Continues to Hit New Highs: Next Move?

The cannabis sector has had its ups and downs over the last year, but there are certain stocks that are almost always...